High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021

ハイスループットスクリーニングの世界市場予測(~ 2021):細胞アッセイ、ラボオンチップ、バイオインフォマティクス、ウルトラハイスループットスクリーニング、ラベルフリー技術

◆タイトル:High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021
◆商品コード:MAM-BT-2220
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年11月24日
◆ページ数:255
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ハイスループットスクリーニングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、市場環境分析、技術別分析、用途別分析、製品別分析、需要先別分析、ハイスループットスクリーニングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・ハイスループットスクリーニングの世界市場:市場インサイト
・ハイスループットスクリーニングの世界市場:市場概観/市場動向
・ハイスループットスクリーニングの世界市場:市場シェア分析
・ハイスループットスクリーニングの世界市場:市場環境分析
・ハイスループットスクリーニングの世界市場:技術別分析/市場規模
・ハイスループットスクリーニングの世界市場:用途別分析/市場規模
・ハイスループットスクリーニングの世界市場:製品別分析/市場規模
・ハイスループットスクリーニングの世界市場:需要先別分析/市場規模
・ハイスループットスクリーニングのアジア市場規模予測
・ハイスループットスクリーニングのヨーロッパ市場規模予測
・ハイスループットスクリーニングのアメリカ市場規模予測
・ハイスループットスクリーニングの世界市場動向
・ハイスループットスクリーニングの世界市場:競争状況
・ハイスループットスクリーニングの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

The global high-throughput screening (HTS) market is projected to reach USD 18.83 Billion by 2021, at a CAGR of 7.8% from 2016 to 2021. The market growth can be attributed to a number of factors such as growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. Label-free technology and automation and miniaturization of HTS techniques are the key trends of this market. However, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.
In this report the global market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the market is segmented into consumables and reagents, instruments, & software and services. In 2015, consumables and reagents accounted for the largest share of the global high-throughput screening products and services market. The availability of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market.

Based on technology, the market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment). The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting. In 2015, 2D cell culture accounted for the largest share of the global market, by technology. The factors contributing to the growth of this technology segment includes low cost, ease of use, and the ability to use cell-based assays in multiwell microplates together with automated workstations.

Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories. In 2015, target identification accounted for the largest share in the global HTS application market. The increasing adoption of HTS technique for the identification of targets is the major factor contributing for the largest share of this segment.

Furthermore, on the basis of end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries. The pharmaceutical and biotechnology companies segment accounted for the largest share in the global HTS market, by end users. The extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications is the major factor driving the growth of this market.

In 2015, North America accounted for the largest share of the global high-throughput screening market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the large spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. Increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding are some factors that will fuel the growth of HTS market in these regions.

The major players in the high-throughput screening market are Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 36)
4.1 High-Throughput Screening: Market Overview
4.2 Asia-Pacific: High-Throughput Screening Services Market, By Type
4.3 Market: Geographic Snapshot
4.4 Market Size, By Application
4.5 Market: Geographic Mix

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
5.2.1.2 Rising Government Funding
5.2.1.3 Increasing R&D Spending
5.2.1.4 Technological Advancements
5.2.2 Market Restraints
5.2.2.1 Capital-Intensive Nature of HTS
5.2.2.2 Complexities in the Field of Assay Development
5.2.3 Market Opportunities
5.2.3.1 High Growth Opportunities in Emerging Markets
5.2.3.2 Growing Research Activities in Toxicology and Stem Cells

6 Industry Insights (Page No. – 47)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Threat of Substitutes
6.2.3 Bargaining Power of Suppliers
6.2.4 Bargaining Power of Buyers
6.2.5 Competitive Rivalry
6.3 Technological Trends
6.3.1 Label-Free Technology, an Emerging Trend
6.3.2 Automation & Miniaturization of HTS Techniques
6.4 HTS in Drug Discovery Process

7 High-Throughput Screening Market, By Product & Service (Page No. – 51)
7.1 Introduction
7.2 Consumables & Reagents
7.3 Instruments
7.4 Software & Services

8 High-Throughput Screening Market, By Technology (Page No. – 57)
8.1 Introduction
8.2 Cell-Based Assays
8.2.1 2d Cell Culture
8.2.2 3D Cell Culture
8.2.2.1 Scaffold-Based Technology
8.2.2.1.1 Hydrogels
8.2.2.1.1.1 Animal-Derived Hydrogels
8.2.2.1.1.2 Alginate/Agarose
8.2.2.1.1.3 Synthetic Hydrogels
8.2.2.1.2 Inert Matrix/Solid Scaffolds
8.2.2.2 Scaffold-Free Technology
8.2.2.2.1 Microplates
8.2.2.2.2 Hanging-Drop Plates
8.2.2.2.3 Ultra-Low Binding Plates
8.2.2.2.4 Other Scaffold-Free Technologies
8.2.3 Perfusion Cell Culture
8.3 Lab-On-A-Chip
8.4 Ultra-High-Throughput Screening
8.5 Label-Free Technology
8.6 Bioinformatics

9 High-Throughput Screening Market, By Application (Page No. – 85)
9.1 Introduction
9.2 Target Identification
9.3 Primary Screening
9.4 Toxicology Assessment
9.5 Other Applications

10 High-Throughput Screening Market, By End User (Page No. – 92)
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Companies
10.3 Academic and Government Research Institutes
10.4 Contract Research Organizations
10.5 Other End Users

11 High-Throughput Screening Market, By Region (Page No. – 99)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 197)
12.1 Introduction
12.2 Strategic Overview
12.3 Market Share Analysis
12.4 Competitive Situation and Trends
12.4.1 Product Launches and Upgrades
12.4.2 Agreements, Collaborations, and Partnerships
12.4.3 Expansions
12.4.4 Acquisitions
12.4.5 Other Developments

13 Company Profiles (Page No. – 206)
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 Agilent Technologies, Inc.
13.3 Danaher Corporation
13.4 Perkinelmer, Inc.
13.5 Thermo Fisher Scientific Inc.
13.6 Axxam S.P.A.
13.7 Tecan Group Ltd.
13.8 Bio-Rad Laboratories, Inc.
13.9 Hamilton Company
13.10 Sigma-Aldrich Corporation (A Division of Merck Millipore)
13.11 Aurora Biomed, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 236)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details

List of Tables (237 Tables)

Table 1 Impact Analysis: Market Drivers
Table 2 Impact Analysis: Market Restraints
Table 3 Impact Analysis: Market Opportunities
Table 4 High-Throughput Screening Market Size, By Product, 2016–2021 (USD Million)
Table 5 High-Throughput Screening Consumables & Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 6 High-Throughput Screening Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 7 High-Throughput Screening Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 8 Market Size, By Technology, 2014–2021 (USD Million)
Table 9 Market Size for Cell-Based Assays, By Type, 2014–2021 (USD Million)
Table 10 Market Size for Cell-Based Assays, By Country, 2014–2021 (USD Million)
Table 11 Market Size for 2d Cell Culture, By Country, 2014–2021 (USD Million)
Table 12 Market Size for 3D Cell Culture, By Type, 2014–2021 (USD Million)
Table 13 Market Size for 3D Cell Culture, By Country, 2014–2021 (USD Million)
Table 14 Market Size for Scaffold-Based Technology, By Type, 2014–2021 (USD Million)
Table 15 Market Size for Scaffold-Based Technology, By Country, 2014–2021 (USD Million)
Table 16 Market Size for Hydrogels, By Type, 2014–2021 (USD Million)
Table 17 Market Size for Hydrogels, By Country, 2014–2021 (USD Million)
Table 18 Market Size for Animal-Derived Hydrogels, By Type, 2014–2021 (USD Million)
Table 19 Market Size for Animal-Derived Hydrogels, By Country, 2014–2021 (USD Million)
Table 20 Market Size for Matrigel, By Country, 2014–2021 (USD Million)
Table 21 Market Size for Collagen, By Country, 2014–2021 (USD Million)
Table 22 Market Size for Alginate/Agarose, By Country, 2014–2021 (USD Million)
Table 23 Market Size for Synthetic Hydrogels, By Country, 2014–2021 (USD Million)
Table 24 Market Size for Inert Matrix/Solid Scaffolds, By Country, 2014–2021 (USD Million)
Table 25 Market Size for Scaffold-Free Technology, By Type, 2014–2021 (USD Million)
Table 26 Market Size for Scaffold-Free Technology, By Country, 2014–2021 (USD Million)
Table 27 Market Size for Microplates, By Country, 2014–2021 (USD Million)
Table 28 Market Size for Hanging-Drop Plates, By Country, 2014–2021 (USD Million)
Table 29 Market Size for Ultra-Low Binding Plates, By Country, 2014–2021 (USD Million)
Table 30 Market Size for Other Scaffold-Free Technologies, By Country, 2014–2021 (USD Million)
Table 31 Market Size for Perfusion Cell Culture, By Country, 2014–2021 (USD Million)
Table 32 Market Size for Lab-On-A-Chip, By Country, 2014–2021 (USD Million)
Table 33 Ultra-High-Throughput Screening Market Size, By Country, 2014–2021 (USD Million)
Table 34 Market Size for Label-Free Technology, By Country, 2014–2021 (USD Million)
Table 35 Market Size for Bioinformatics, By Country, 2014–2021 (USD Million)
Table 36 Market Size, By Application, 2014–2021 (USD Million)
Table 37 Market Size for Target Identification, By Country, 2014–2021 (USD Million)
Table 38 Market Size for Primary Screening, By Country, 2014–2021 (USD Million)
Table 39 Market Size for Toxicology Assessment, By Country, 2014–2021 (USD Million)
Table 40 Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 41 Market Size, By End User, 2014–2021 (USD Million)
Table 42 Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2014–2021 (USD Million)
Table 43 Market Size for Academic and Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 44 Market Size for Contract Research Organizations, By Country, 2014–2021 (USD Million)
Table 45 Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 46 Market Size, By Region, 2014–2021 (USD Million)
Table 47 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 48 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 49 North America: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 50 North America: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 51 North America: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 52 North America: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 53 North America: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 54 North America: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 55 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 56 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 57 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 58 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 59 U.S.: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 60 U.S.: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 61 U.S.: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 62 U.S.: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 63 U.S.: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 64 U.S.: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 65 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 66 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 67 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 68 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 69 Canada: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 70 Canada: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 71 Canada: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 72 Canada: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 73 Canada: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 74 Canada: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 75 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 76 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 77 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 78 Pharmaceutical Industry R&D Expenditure in Europe, By Country, 2014 (USD Million)
Table 79 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 80 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 81 Europe: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 82 Europe: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 83 Europe: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 84 Europe: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 85 Europe: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 86 Europe: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 87 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 88 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 89 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 90 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 91 Germany: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 92 Germany: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 93 Germany: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 94 Germany: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 95 Germany: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 96 Germany: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 97 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 98 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 99 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 100 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 101 U.K.: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 102 U.K.: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 103 U.K.: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 104 U.K.: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 105 U.K.: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 106 U.K.: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 107 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 108 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table 109 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 110 France: Market Size, By Technology, 2014–2021 (USD Million)
Table 111 France: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 112 France: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 113 France: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 114 France: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 115 France: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 116 France: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 117 France: Market Size, By Application, 2014–2021 (USD Million)
Table 118 France: Market Size, By Product, 2014–2021 (USD Million)
Table 119 France: Market Size, By End User, 2014–2021 (USD Million)
Table 120 Italy: Market Size, By Technology, 2014–2021 (USD Million)
Table 121 Italy: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 122 Italy: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 123 Italy: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 124 Italy: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 125 Italy: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 126 Italy: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 127 Italy: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 128 Italy: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 129 Italy: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 130 Spain: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 131 Spain: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 132 Spain: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 133 Spain: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 134 Spain: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 135 Spain: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 136 Spain: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 137 Spain: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 138 Spain: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 139 Spain: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 140 RoE: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 141 RoE: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 142 RoE: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 143 RoE: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 144 RoE: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 145 RoE: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 146 RoE: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 147 RoE: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 148 RoE: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 149 RoE: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 150 APAC: High-Throughput Screening Market Size, By Country, 2014–2021 (USD Million)
Table 151 APAC: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 152 APAC: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 153 APAC: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 154 APAC: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 155 APAC: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 156 APAC: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 157 APAC: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 158 APAC: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 159 APAC: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 160 APAC: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 161 Japan: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 162 Japan: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 163 Japan: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 164 Japan: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 165 Japan: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 166 Japan: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 167 Japan: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 168 Japan: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 169 Japan: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 170 Japan: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 171 China: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 172 China: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 173 China: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 174 China: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 175 China: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 176 China: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 177 China: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 178 China: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 179 China: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 180 China: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 181 India: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 182 India: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 183 India: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 184 India: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 185 India: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 186 India: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 187 India: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 188 India: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 189 India: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 190 India: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 191 RoAPAC: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 192 RoAPAC: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 193 RoAPAC: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 194 RoAPAC: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 195 RoAPAC: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 196 RoAPAC: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 197 RoAPAC: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 198 RoAPAC: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 199 RoAPAC: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 200 RoAPAC: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 201 RoW: High-Throughput Screening Market Size, By Region, 2014–2021 (USD Million)
Table 202 RoW: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 203 RoW: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 204 RoW: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 205 RoW: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 206 RoW: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 207 RoW: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 208 RoW: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 209 RoW: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 210 RoW: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 211 RoW: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 212 Latin America: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 213 Latin America: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 214 Latin America: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 215 Latin America: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 216 Latin America: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 217 Latin America: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 218 Latin America: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 219 Latin America: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 220 Latin America: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 221 Latin America: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 222 Middle East and Africa: High-Throughput Screening Market Size, By Technology, 2014–2021 (USD Million)
Table 223 Middle East and Africa: Cell-Based Assays Market Size, By Type, 2014–2021 (USD Million)
Table 224 Middle East and Africa: 3D Cell Culture Market Size, By Type, 2014–2021 (USD Million)
Table 225 Middle East and Africa: Scaffold-Based Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 226 Middle East and Africa: Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 227 Middle East and Africa: Animal-Derived Hydrogels Market Size, By Type, 2014–2021 (USD Million)
Table 228 Middle East and Africa: Scaffold-Free Technologies Market Size, By Type, 2014–2021 (USD Million)
Table 229 Middle East and Africa: High-Throughput Screening Market Size, By Application, 2014–2021 (USD Million)
Table 230 Middle East and Africa: High-Throughput Screening Market Size, By Product, 2014–2021 (USD Million)
Table 231 Middle East and Africa: High-Throughput Screening Market Size, By End User, 2014–2021 (USD Million)
Table 232 Market Developments, By Company, 2013–2016
Table 233 Product Launches and Upgrades, 2013–2016
Table 234 Agreements, Collaborations, and Partnerships, 2013–2016
Table 235 Expansions, 2013–2016
Table 236 Acquisitions, 2013–2016
Table 237 Other Developments, 2013–2016

List of Figures (39 Figures)

Figure 1 High-Throughput Screening Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Global High-Throughput Screening Market, By Products and Services, 2016 vs 2021 (USD Million)
Figure 8 Global High-Throughput Screening Market, By Application, 2016 vs 2021 (USD Million)
Figure 9 Global High-Throughput Screening Market, By Technology, 2016 vs 2021 (USD Million)
Figure 10 Global High-Throughput Screening Market, By End User, 2016 vs 2021 (USD Million)
Figure 11 Geographic Snapshot: High-Throughput Screening Market
Figure 12 Adoption of Open Innovative Models By Pharmaceutical & Biotechnology Companies is Propelling Growth in the High-Throughput Screening Market
Figure 13 Pharmaceutical & Biotechnology Companies Commanded the Largest Share of the Asia-Pacific High-Throughput Screening Market in 2015
Figure 14 The U.S. Accounted for the Largest Share of the High-Throughput Screening Technologies Market in 2015
Figure 15 The Target Identification Segment Will Continue to Dominate the High-Throughput Screening Market in 2021
Figure 16 North America to Witness the Highest Growth Rate in the High-Throughput Screening Market During the Forecast Period
Figure 17 High-Throughput Screening Market: Drivers, Restraints, and Opportunities
Figure 18 Pharmaceutical R&D Expenditure, By Geography, 2000 vs 2010 vs 2014
Figure 19 Porter’s Five Forces Analysis
Figure 20 Drug Discovery Process
Figure 21 High-Throughput Screening Market Segmentation, By Product
Figure 22 High-Throughput Screening Market, By Technology, 2016 vs 2021 (USD Million)
Figure 23 High-Throughput Screening Market for Cell-Based Assays, By Type, 2016 vs 2021 (USD Million)
Figure 24 High-Throughput Screening Market for 3D Cell Culture, By Type, 2016 vs 2021 (USD Million)
Figure 25 High-Throughput Screening Market, By Application, 2016
Figure 26 High-Throughput Screening Market Size, By End User, 2016-2021 (USD Million)
Figure 27 High-Throughput Screening Market: Geographic Snapshot (2016)
Figure 28 North America: HTS Market Snapshot
Figure 29 Asia-Pacific: HTS Market Snapshot
Figure 30 Key Developments in the High-Throughput Screening Market, 2013–2016
Figure 31 Global High-Throughput Screening Market Share Analysis, By Key Player, 2015
Figure 32 Financial Performances of the Leading Market Players
Figure 33 Agilent Technologies, Inc.: Company Snapshot
Figure 34 Danaher Corporation: Company Snapshot
Figure 35 Perkinelmer, Inc.: Company Snapshot
Figure 36 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 37 Tecan Group Ltd.: Company Snapshot
Figure 38 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 39 Merck Millipore: Company Snapshot

【レポートのキーワード】

ハイスループットスクリーニング、細胞アッセイ、ラボオンチップ、バイオインフォマティクス、ウルトラハイスループットスクリーニング、ラベルフリー技術、試薬、装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ハイスループットスクリーニングの世界市場予測(~ 2021):細胞アッセイ、ラボオンチップ、バイオインフォマティクス、ウルトラハイスループットスクリーニング、ラベルフリー技術]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆